Eloxx Pharmaceuticals, Inc. (ELOX) Corporate Subsidiaries
Eloxx Pharmaceuticals, Inc. (ELOX) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ELOX
CIK: 1035354
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Baker Tilly US, LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerKristen Godsoe
Audit LocationTewksbury, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| EFFECT | 2026-09-18 | — | EFFECT Filing | 9999999995-26-003014 | View SEC Doc Filr Page |
| S-1 | 2026-09-11 | — | S-1 | 0001193125-26-389422 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001699737-26-000018 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001104659-26-097268 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001193125-26-345032 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001193125-26-344964 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-27 | — | SCHEDULE 13G Filing | 0001716774-26-000020 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-17 | — | SCHEDULE 13G Filing | 0001104659-26-075290 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-17 | — | SCHEDULE 13G Filing | 0000919574-26-004022 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-10 | 4 Filing | 0000919574-26-004021 | View SEC Doc Filr Page |
| 3 | 2026-06-17 | 2026-06-05 | 3 Filing | 0000919574-26-004020 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-16 | — | SCHEDULE 13G Filing | 0000935836-26-000321 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-16 | — | SCHEDULE 13G Filing | 0001440771-26-000006 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-15 | — | SCHEDULE 13G Filing | 0002005369-26-000037 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-08 | 4 | 0001193125-26-266279 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-08 | 4 | 0001193125-26-266278 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-08 | 4 | 0001193125-26-266276 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-10 | 4 | 0001193125-26-266277 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-08 | 4 | 0001193125-26-266275 | View SEC Doc Filr Page |
| 424B4 | 2026-06-09 | — | 424B4 | 0001193125-26-263914 | View SEC Doc Filr Page |
| EFFECT | 2026-06-08 | — | EFFECT Filing | 9999999995-26-001918 | View SEC Doc Filr Page |
| CERT | 2026-06-08 | — | CERT Filing | 0001354457-26-000547 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-06-05 | — | SCHEDULE 13G/A Filing | 0000919574-26-003846 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-05-27 | 4 Filing | 0000919574-26-003845 | View SEC Doc Filr Page |
| S-1/A | 2026-06-04 | — | S-1/A | 0001193125-26-257750 | View SEC Doc Filr Page |